Back
Catalyst Pharmaceuticals Stock Price Chart

Missed investing in Uber? Don't Miss Mode.
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
77
CPRX
Catalyst Pharmaceuticals
Last Price:
$23.83
Seasonality Move:
15.63%
7 Day Trial
ALL ACCESS PASS
$
7

FREE Copy of "2025 Gold Forecast: A Perfect Storm for Demand"
Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report here-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CPRX is experiencing slight buying pressure.
Catalyst Pharmaceuticals Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 23.79 | Sell |
20-day SMA: | 23.27 | Buy |
50-day SMA: | 23.02 | Buy |
200-day SMA: | 21.44 | Buy |
8-day EMA: | 23.49 | Sell |
20-day EMA: | 22.81 | Buy |
50-day EMA: | 17.88 | Buy |
200-day EMA: | 7.1 | Buy |
Catalyst Pharmaceuticals Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.47 | Buy |
Relative Strength Index (14 RSI): | 50.34 | Buy |
Chaikin Money Flow: | 295098 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (22.14 - 23.94) | Buy |
Bollinger Bands (100): | (21.41 - 23.77) | Buy |
Catalyst Pharmaceuticals Technical Analysis
Apr 28 | Apr 29 | Apr 30 | May 1 | May 2 | May 5 | May 6 | May 7 | May 8 | May 9 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | May | |||||||||
28 | 29 | 30 | 01 | 02 | 05 | 06 | 07 | 08 | 09 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Catalyst Pharmaceuticals Stock
Is Catalyst Pharmaceuticals Stock a Buy?
-
Catalyst Pharmaceuticals share price is 23.37 while CPRX 8-day simple moving average is 23.79, which is a Sell signal.
-
The stock price of CPRX is 23.37 while Catalyst Pharmaceuticals 20-day SMA is 23.27, which makes it a Buy.
-
Catalyst Pharmaceuticals 50-day simple moving average is 23.02 while CPRX share price is 23.37, making it a Buy technically.
-
CPRX stock price is 23.37 and Catalyst Pharmaceuticals 200-day simple moving average is 21.44, creating a Buy signal.
CPRX Technical Analysis vs Fundamental Analysis
Buy
77
Catalyst Pharmaceuticals (CPRX)
is a Buy
Is Catalyst Pharmaceuticals a Buy or a Sell?
-
Catalyst Pharmaceuticals stock is rated a BuyThe current Catalyst Pharmaceuticals [CPRX] share price is $23.37. The Score for CPRX is 77, which is 54% above its historic median score of 50, and infers lower risk than normal.
Catalyst Pharmaceuticals Stock Info
Market Cap:
2.9B
Price in USD:
23.37
Share Volume:
1.6M
Catalyst Pharmaceuticals 52-Week Range
52-Week High:
26.16
52-Week Low:
14.75
Buy
77
Catalyst Pharmaceuticals (CPRX)
is a Buy
Catalyst Pharmaceuticals Share Price Forecast
-
What is the Catalyst Pharmaceuticals stock price today?The Catalyst Pharmaceuticals stock price is 23.37 USD today.
-
Will CPRX stock go up or go down?Catalyst Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators
-
Is Catalyst Pharmaceuticals overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Catalyst Pharmaceuticals is not overvalued.
Is Catalyst Pharmaceuticals Stock a Buy?
-
Catalyst Pharmaceuticals share price is 23.37 while CPRX 8-day exponential moving average is 23.49, which is a Sell signal.
-
The stock price of CPRX is 23.37 while Catalyst Pharmaceuticals 20-day EMA is 22.81, which makes it a Buy.
-
Catalyst Pharmaceuticals 50-day exponential moving average is 17.88 while CPRX share price is 23.37, making it a Buy technically.
-
CPRX stock price is 23.37 and Catalyst Pharmaceuticals 200-day simple moving average is 7.10, creating a Buy signal.
Fundamental Analysis of Catalyst Pharmaceuticals
Is Catalyst Pharmaceuticals a good investment?
-
Analysts estimate an earnings increase this quarter of $0.05 per share, an increase next quarter of $0.14 per share, an increase this year of $0.20 per share, and an increase next year of $0.02 per share.
Technical Analysis of Catalyst Pharmaceuticals
Should I short Catalyst Pharmaceuticals stock?
-
CPRX Moving Average Covergence Divergence (MACD) indicator is 1.47, suggesting Catalyst Pharmaceuticals is a Buy
-
Catalyst Pharmaceuticals Relative Strength Index (RSI) is 50.34, which suggest Catalyst Pharmaceuticals is overbought
-
The Bollinger Bands (25) for Catalyst Pharmaceuticals is (22.14 - 23.94), which suggest Catalyst Pharmaceuticals is a Buy
-
The Bollinger Bands (100) for Catalyst Pharmaceuticals is (21.41 - 23.77), which suggest Catalyst Pharmaceuticals is a Buy
* Catalyst Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.